Sleep and physical activity: a cross-sectional objective profile of people with rheumatoid arthritis

Sean McKenna, Marie Tierney, Aoife O'Neill, Alexander Fraser, Norelee Kennedy, Sean McKenna, Marie Tierney, Aoife O'Neill, Alexander Fraser, Norelee Kennedy

Abstract

Regular physical activity (PA) is important for people with rheumatoid arthritis (RA). Poor sleep is a common complaint among people with RA, which may have an influence on their PA levels. There is a lack of objective information regarding total sleep time (TST) and PA duration in this population. A cross-sectional study design was used. SenseWear Pro3 Armband(R)TM is used to measure TST and total PA duration. Four valid days, with 95% wear time necessary for inclusion in final results. Disease activity and function were measured using the DAS-28, HAQ and VAS. Data analysis carried out using SPSS v22. Seventy-five (75) participants completed monitoring period, with 51 (68%) meeting modified PA duration guidelines. Data with 95% wear time over a minimum of 4 days were available for 32 recorded participants, with a mean TST of 5.7 (SD_1.11) hours per night and a median 1.25 (IQR_1.88) hours of daily PA. TST had a positive significant relationship with PA (p = 0.018); PA demonstrated a negative significant relationship with functional limitations (p = 0.009) and correlated with lower CRP levels; CRP levels had in turn a significant relationship to global health (p = 0.034). Total sleep time was low for people with RA. People with RA who are more physically active have longer TST. These findings provide an objective profile of TST and PA duration in people with RA and suggest a relationship between increased PA duration and longer TST. Further research is needed to confirm these novel findings.

Keywords: Accelerometer; Exercise; Inflammatory arthritis; Pain; Physiotherapy; Sleep.

References

    1. Arch Intern Med. 2012 Jan 9;172(1):48-57
    1. Arthritis Care Res (Hoboken). 2016 Jan;68(1):81-90
    1. J Clin Hypertens (Greenwich). 2011 Oct;13(10):739-43
    1. J Rheumatol. 2007 Jan;34(1):10-5
    1. BMC Musculoskelet Disord. 2017 Mar 29;18(1):131
    1. Cochrane Database Syst Rev. 2009 Oct 07;(4):CD006853
    1. Br J Sports Med. 2010 Jul;44(9):657-64
    1. Eur Neuropsychopharmacol. 2010 Jan;20(1):1-17
    1. Cochrane Database Syst Rev. 2013 Aug 23;(8):CD008322
    1. Arthritis Care Res (Hoboken). 2015 Aug;67(8):1054-62
    1. J Psychosom Res. 2004 May;56(5):503-10
    1. Int J Surg. 2014 Dec;12(12):1495-9
    1. Int J Qual Stud Health Well-being. 2015 Oct 12;10:28578
    1. PLoS One. 2014 Apr 24;9(4):e95824
    1. J Phys Act Health. 2012 Feb;9(2):225-36
    1. Sleep. 1989 Dec;12(6):529-36
    1. Arthritis Care Res (Hoboken). 2011 Nov;63(11):1613-9
    1. J Rheumatol. 1988 Oct;15(10):1480-8
    1. Sleep. 2006 Jan;29(1):85-93
    1. Sleep. 2003 May 1;26(3):342-92
    1. J Physiother. 2012;58(3):157-63
    1. J Rheumatol. 1997 Sep;24(9):1697-702
    1. Arthritis Care Res (Hoboken). 2013 Jun;65(6):888-95
    1. Pain. 2012 Jan;153(1):107-12
    1. Disabil Rehabil. 2017 Jun 2;:1-7
    1. Clin Rheumatol. 2015 Dec;34(12):2029-39
    1. Arthritis Rheum. 2008 Jan 15;59(1):42-50
    1. Rheumatol Int. 2015 Oct;35(10):1655-64
    1. Disabil Rehabil. 2015 ;37(25):2359-66
    1. Phys Ther. 2011 Sep;91(9):1367-76
    1. RMD Open. 2015 Feb 18;1(1):e000026
    1. J Gerontol A Biol Sci Med Sci. 2011 Oct;66(10):1108-13
    1. J Phys Act Health. 2012 Sep;9(7):1036-48
    1. Rheumatol Int. 2017 Jun;37(6):963-974
    1. Clin Sports Med. 2005 Apr;24(2):355-65, xi
    1. Int J Behav Nutr Phys Act. 2012 Jul 09;9:84
    1. J Clin Rheumatol. 2005 Jun;11(3 Suppl):S39-44
    1. Ann Rheum Dis. 2015 Feb;74(2):326-32
    1. Phys Ther. 2004 Oct;84(10):934-72
    1. J Appl Physiol (1985). 2008 Sep;105(3):977-87
    1. Breast Cancer Res Treat. 2014 Apr;144(2):361-9

Source: PubMed

3
Předplatit